Background. In general, antiarrhythmic agents that prolong the action potential duration (APD) have attenuated effects on repolarization at short cycle lengths (reverse frequency dependence), and this may limit their efficacy for controlling ventricular arrhythmias. The frequency-dependent effects of amiodarone on repolarization may differ from those of other antiarrhythmic agents and have not been determined in humans.
dependent actions on Vmax and ventricular conduction has further complicated the understanding of its overall pharmacology. [4] [5] [6] In vitro and in vivo studies in the drug-free state have shown a close correlation between ventricular action potential duration (APD) and the ventricular effective refractory period (VERP).7-10 Both parameters progressively shorten with decreases in ventricular paced cycle lengths. Numerous studies on the rate-related effects of various antiarrhythmic agents such as sotalol,1112 sematilide,13 quinidine,14 dofetilide,15 and N-acetylprocainamide16 on repolarization have demonstrated that the prolongation of the APD by these agents is attenuated at short ventricular paced cycle lengths. This phenomenon has been termed "reverse frequency dependence."7 '16 However, a recent study in open-chest pen-tobarbitalized dogs did not find reverse frequency dependence of the repolarization interval (determined from the test site QT interval) after chronic amiodarone therapy.5 This is a potentially important finding because attenuation of the APD-prolonging effects of antiarrhythmic agents at short cycle lengths may decrease drug efficacy during clinical ventricular tachyarrhythmias. 16 In addition, reentrant ventricular arrhythmias are more likely to be induced when the APD and effective refractory period are short,'7-20 whereas torsade de pointes tends to occur when the APD is markedly prolonged, particularly at slow heart rates. [21] [22] [23] [24] [25] [26] Although frequency-related electrophysiologic effects of amiodarone may play an important role in the antiarrhythmic efficacy of this compound and its low incidence of proarrhythmia, no study has reported the frequencydependent actions of amiodarone on ventricular repolarization in humans. The purpose of this study was twofold: (1) to determine the frequency-dependent actions of amiodarone on ventricular repolarization and conduction and (2) to delineate potential differences in frequencydependent actions between patients treated short term versus those treated long term with amiodarone.
Methods

Patient Population
Patients with sustained symptomatic ventricular tachycardia (VT), ventricular fibrillation, aborted sudden death, or syncope secondary to ventricular arrhythmias were studied. Those with unstable angina, myocardial infarction within the previous month, and sustained ventricular arrhythmias occurring only in the setting of an acute myocardial infarction were excluded. Two groups of patients undergoing electrophysiologic studies for the evaluation of malignant clinical ventricular arrhythmias were examined: Group A consisted of consecutive patients undergoing electrophysiologic study both at baseline in the drug-free state and after approximately 11 days of oral amiodarone loading at 1600 mg/d, and group B was a separate patient cohort undergoing electrophysiologic study after treatment for .1 year with chronic amiodarone at a maintenance dose of 300 to 400 mg/d after a loading regimen. All patients were chemically and clinically euthyroid at the time of their electrophysiologic evaluation. The study was 
Nineteen patients were treated with amiodarone for a mean of 11 days (group A, 1621±162 mg/d), and 15 patients were treated for .1 year (group B, 380±56 mg/d). Except for the number of days of therapy and treatment dose, there were no significant differences between the two groups' clinical characteristics (Table) . APD and VERP in Group A After amiodarone loading, group A patients had a significant (10% to 13%, P<.001) prolongation of the APD90 (Fig 1) compared with baseline of approximately 30 milliseconds during ventricular pacing at all cycle lengths tested (300 to 600 milliseconds). The percent increase from baseline in the APD90 in group A patients was 11.4%, 10.1%, 13.0%, 13.0%, and 12.3% during ventricular paced cycle lengths of 600, 500, 400, 350, and 300 milliseconds, respectively. Thus, the degree of APD90 prolongation compared with baseline was relatively constant, and no frequency-dependent effects of amiodarone on the APD were observed.
As with the APD90, the VERP in group A was also prolonged by amiodarone (P<.001) at all paced cycle lengths compared with baseline (Fig 2) . The increase in VERP magnitude during amiodarone therapy in group A patients was examined over the range of paced cycle lengths using repeated-measures ANOVA. This demonstrated a significantly greater prolongation of the VERP magnitude at longer as compared with shorter paced cycle lengths (P=.04). The percent increase (Fig  2) from baseline in the VERP was 21.8%, 22.6%, 21.0%, 19.8%, and 16.9% during ventricular paced cycle lengths of 600, 500, 400, 350, and 300 milliseconds, respectively. There were no significant differences in the percent increase in VERP at any of the examined cycle lengths. Thus, at short paced cycle lengths there was a significant attenuation of the magnitude of amiodaroneinduced VERP prolongation but not in the relative increase in the VERP, and the VERP during amiodarone therapy remained significantly prolonged at the shortest paced cycle length (300 milliseconds) by 33+20 milliseconds (16.9%, P<.001 compared with baseline). Effects on Conduction in Group A Compared with baseline, amiodarone significantly (P<.01) increased the QRS duration (Fig 3) at all paced cycle lengths .500 milliseconds. The maximal prolongation of the QRS duration compared with baseline was 28%. The degree of QRS prolongation was significantly greater at shorter than at longer paced cycle lengths (P<.01), indicative of frequency-dependent effects of amiodarone on ventricular conduction. We found that amiodarone-induced prolongation of the APD90 occurred over a wide range of frequencies without significant attenuation during rapid ventricular pacing. Similar findings evaluating repolarization intervals (derived from the test site QT interval) in pentobarbitalized dogs have been reported.5 Both of these observations are most likely secondary to block of IK, 16, [36] [37] [38] although other processes also may be involved. The unique frequency-dependent features of amiodarone on repolarization may be related to the finding of Balser et a138 that amiodarone-induced block of outward currents in guinea pig ventricular cells occurs throughout the cardiac cycle, mildly increasing during depolarization and slightly decreasing during repolarization. This would allow relatively steady-state block of outward currents during the interpulse interval, and it would not be expected that 1K block would be reduced during short cycle lengths. In addition, the nonselective block by amiodarone of potassium currents may contribute to the lack of frequency-dependent effects on repolarization. [36] [37] [38] [39] [40] In contrast to the APD90, there was an attenuation in the magnitude of amiodarone-induced VERP prolongation at short cycle lengths, although the VERP nevertheless remained significantly prolonged at the shortest cycle length examined. No frequency-dependent effects on the percent increase in the VERP by amiodarone were observed, and it is unclear whether the absolute or relative prolongation of the VERP is the more clinically meaningful parameter.
Ratio of VERP and APD(0 in Group
VERP prolongation did not appear to be fully accounted for by APD90 prolongation in our study. The significant prolongation of the VERP/APD90 ratio (measured at twice diastolic threshold) compared with baseline at long cycle lengths appears to reflect a composite of time-dependent as well as voltage-dependent effects. The result of these time-dependent effects is a significant lengthening of the VERP at long cycle lengths (about 50 milliseconds, compared with baseline) without an equivalent increase in APD90, which was prolonged by approximately 30 milliseconds. These timedependent effects (at twice diastolic threshold) most likely reflect the incomplete recovery of sodium channel blockade after repolarization.8,14,41-43 The relatively rapid kinetics of sodium channel block during depolarization probably results in a high degree of sodium channel block at the end of the plateau, which does not fully dissipate by the end of repolarization.8,41-43 Subsequently, the VERP is prolonged to a greater extent than the APD90. Such time-dependent effects on refractoriness have been demonstrated in guinea pig ventricular free wall tissues for lidocaine,41 a drug with sodium channel blocking kinetics similar to amiodarone,31 and that also preferentially binds to inactivated sodium channels. 44 During rapid pacing the QRS duration is markedly prolonged, reflecting the shortened diastolic interval and less dissipation of amiodarone-induced sodium channel block at phase 0 of the APD, whereas time-dependent effects on refractoriness are not increased at short cycle lengths. This most likely reflects a balance during rapid pacing between less amiodarone binding during the shortened plateau and frequencydependent accumulation of sodium block, resulting in an overall lack of further enhancement of sodium block during the terminal portions of phase 3 (where the VERP is determined) compared with long paced cycle lengths. Our findings are in agreement with those in a chronic amiodarone dog model that demonstrated significant time-dependent effects on the VERP at cycle lengths of 300 to 1000 milliseconds. 5 The increase observed at drug-free baseline in the VERP/APD90 ratio at short cycle lengths in the current study probably reflects lack of full recovery of sodium channels during rapid pacing. 41 
Limitations of the Study
The group A and group B patients were different, and, although the clinical parameters of the two patient cohorts were similar, the electrophysiologic comparison is between two separate populations, and the data must be examined with this in mind. It was not feasible to wait >1 year to restudy the same patients because of alterations in patient therapy for clinical reasons, patients moving to a different locale, and intercurrent clinical events; thus, the major analysis of group B is in the pattern of change in their electrophysiologic parameters at different paced cycle lengths and a comparison of the electrophysiologic profile of groups A and B. It was only possible to test a relatively narrow range of cycle lengths (300 to 600 milliseconds) because of sinus interference at longer cycle lengths or hemodynamic instability at shorter cycle lengths. QRS duration was used as a measurement of ventricular conduction velocity and may not be as accurate as directly measured conduction velocity. However, the QRS duration has been shown to correlate highly with conduction changes measured by epicardial mapping.62 Furthermore, the QRS duration has been used to determine frequencydependent conduction slowing, and, as a parameter, it correlates well with changes in Vm. in vitro. 63 The APD90 and VERP were measured at the same RV site; however, it is unlikely that these measurements were obtained from exactly the same cohort of cells. However, the demonstration in humans of a very linear relation between test-site APD90 and VERP substantiates comparing the APDgo with the VERP when both measurements are made at the same catheter site.27 The analysis between electrophysiologic characteristics and the increase in sustained VT cycle length during amiodarone therapy was performed in a small number of patients, and the effects of amiodarone on these parameters in the reentrant circuit may be different from those at the RV recording site. It was only possible to perform the electrophysiologic determinations at twice diastolic threshold, and the possibility cannot be excluded that other frequency-dependent relations might be observed at higher current stimulation.
Conclusions
Amiodarone does not exert frequency-dependent effects on ventricular repolarization; refractoriness is prolonged by both time-and voltage-dependent mechanisms, and amiodarone exerts frequency-dependent effects on ventricular conduction. The overall findings are unique in an antiarrhythmic agent and may contribute to the unusual efficacy of the drug combined with its low incidence of proarrhythmic effects.
